GO:1905706 regulation of mitochondrial ATP synthesis coupled proton transport: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1905706 describes the biological process that regulates mitochondrial ATP synthesis coupled to proton transport, a central node of cellular energy homeostasis.
• The term encompasses both the forward production of ATP by ATP synthase and the reverse hydrolysis of ATP that can occur under pathological conditions.
• Proton leak and uncoupling proteins modulate the proton-motive force and thereby regulate the efficiency of ATP synthesis.
• Key molecular players include respiratory chain complexes, ATP synthase (complex V), uncoupling proteins (UCP1-3), and mitochondrial carriers such as Letm1.
• Dysregulation of this process is implicated in metabolic, cardiovascular, and neurodegenerative disorders, making it a target for therapeutic intervention.
• CRISPR-based knockout, knock-in, and overexpression models are essential to dissect the causal roles of individual regulators in this pathway.
Description
Mitochondrial ATP synthesis coupled to proton transport is the fundamental process by which cells convert the energy stored in the proton gradient across the inner mitochondrial membrane into the universal energy currency, ATP. This process, defined by the Gene Ontology term GO:1905706, encompasses any regulatory mechanism that modulates the rate, efficiency, or directionality of ATP production linked to proton translocation. The term is critical for understanding how cells balance energy supply with metabolic demand, and how this balance is disrupted in disease. Researchers studying metabolism, bioenergetics, and mitochondrial medicine require a precise definition of this process to design experiments that distinguish between changes in ATP synthesis capacity and changes in proton transport regulation. The regulation of mitochondrial ATP synthesis coupled proton transport is not a single molecular event but a systems-level property involving the respiratory chain, uncoupling proteins, and multiple signaling pathways. Consequently, experimental models that manipulate individual genes within this network are indispensable for causal inference.
regulation of mitochondrial ATP synthesis coupled proton transport At A Glance
| GO ID | GO:1905706 |
|---|---|
| GO term | regulation of mitochondrial ATP synthesis coupled proton transport |
| Ontology | biological_process |
| Synonym | None listed in QuickGO |
| Major function | Regulation of ATP production linked to proton translocation across the inner mitochondrial membrane |
| Related cellular component | Mitochondrial inner membrane, respiratory chain complexes, ATP synthase |
| Related molecular functions | Proton transmembrane transporter activity, ATPase activity, uncoupling protein activity |
| Key regulators | Respiratory chain complexes I-IV, ATP synthase (complex V), UCP1-3, Letm1, ANT, phosphate carrier |
| Physiological contexts | Thermogenesis, insulin secretion, immune cell activation, neuronal survival |
| Pathological contexts | Mitochondrial myopathies, cardiomyopathy, neurodegeneration, cancer metabolism, ischemia-reperfusion injury |
What Is GO:1905706?
GO:1905706, regulation of mitochondrial ATP synthesis coupled proton transport, is a biological process that encompasses any mechanism that modulates the synthesis of ATP in mitochondria when that synthesis is coupled to the transport of protons across the inner mitochondrial membrane. In other words, it describes how cells control the conversion of the proton-motive force into ATP, including changes in the rate of ATP production, the efficiency of coupling, and the reversibility of the ATP synthase reaction. This term does not describe the ATP synthesis reaction itself, but rather the regulatory inputs that adjust it in response to metabolic, hormonal, or pathological signals.
Why Is regulation of mitochondrial ATP synthesis coupled proton transport Important in Cell Biology?
Understanding the regulation of mitochondrial ATP synthesis coupled proton transport is essential because it sits at the intersection of energy metabolism, cell survival, and organismal physiology. Defects in this regulation lead to insufficient ATP production, excessive reactive oxygen species (ROS) generation, and impaired cellular function, which are hallmarks of numerous human diseases including mitochondrial disorders, heart failure, and neurodegeneration. Moreover, the ability to modulate this process pharmacologically or genetically holds therapeutic promise for conditions characterized by energy failure or metabolic inflexibility.
• Determines cellular ATP supply and therefore affects virtually all energy-dependent processes.
• Regulates ROS production, which influences signaling and oxidative stress.
• Controls thermogenesis in brown adipose tissue via uncoupling protein 1.
• Modulates insulin secretion in pancreatic beta cells through ATP-sensitive potassium channels.
• Influences immune cell activation and immunometabolism.
• Its dysregulation contributes to cardiomyopathy and heart failure.
• Is implicated in neuronal survival after ischemic stroke.
• Reverse ATP synthase activity can exacerbate mitochondrial pathologies.
• Provides targets for drugs that modulate mitochondrial efficiency.
• Serves as a biomarker for mitochondrial function in clinical research.
What Happens During regulation of mitochondrial ATP synthesis coupled proton transport?
Proton gradient generation by the respiratory chain
In simple terms: The respiratory chain pumps protons out of the mitochondrial matrix to create a gradient.
The electron transport chain (ETC) complexes I, III, and IV transfer electrons from NADH and FADH2 to oxygen, and in doing so pump protons from the mitochondrial matrix into the intermembrane space. This creates an electrochemical proton gradient, also called the proton-motive force, which stores energy. The regulation of this step directly affects the magnitude of the gradient available for ATP synthesis.
Proton leak and uncoupling
In simple terms: Some protons leak back into the matrix without making ATP, which reduces efficiency.
Proton leak is a regulated process mediated by uncoupling proteins (UCPs) and other mitochondrial carriers. UCP1 in brown adipose tissue dissipates the proton gradient to generate heat, while other UCPs may modulate ROS production and metabolic efficiency. The regulation of proton leak thus directly controls how much of the proton gradient is used for ATP synthesis versus heat or other purposes.
ATP synthesis by ATP synthase
In simple terms: ATP synthase uses the proton gradient to make ATP from ADP and phosphate.
ATP synthase (complex V) is a rotary motor that couples proton translocation back into the matrix with the phosphorylation of ADP to ATP. The enzyme can also work in reverse, hydrolyzing ATP to pump protons, a phenomenon that occurs under certain pathological conditions such as ischemia. Regulation of ATP synthase activity, including its directionality, is a key component of GO:1905706.
Regulation by calcium and signaling pathways
In simple terms: Calcium and other signals tell mitochondria to make more or less ATP.
Mitochondrial calcium uptake stimulates dehydrogenases and ATP synthesis to match energy demand. Signaling pathways such as AMPK and mTOR can also regulate mitochondrial biogenesis and function, indirectly affecting ATP synthesis coupled proton transport. These regulatory inputs ensure that ATP production is tuned to cellular needs.
Reverse activity and pathological remodeling
In simple terms: In disease, ATP synthase can run backwards and waste energy.
In mitochondrial pathologies, ATP synthase may hydrolyze ATP to maintain the proton gradient, leading to energy depletion. Inhibition of this reverse activity has been shown to restore energy homeostasis in disease models. This highlights the importance of regulatory mechanisms that control the direction of the ATP synthase reaction.
Key Genes Involved in GO:1905706 regulation of mitochondrial ATP synthesis coupled proton transport
The following genes and proteins are central to the regulation of mitochondrial ATP synthesis coupled proton transport, based on their established roles in the respiratory chain, uncoupling, and mitochondrial transport.
| Gene | Major Role | Research Relevance |
|---|---|---|
| MT-ATP6 | Subunit of ATP synthase (complex V) | Mutations cause mitochondrial myopathies and neuropathy |
| MT-ATP8 | Subunit of ATP synthase | Associated with cardiomyopathy and metabolic disorders |
| UCP1 | Uncoupling protein 1, mediates proton leak for thermogenesis | Target for obesity and metabolic research |
| UCP2 | Uncoupling protein 2, modulates ROS and insulin secretion | Linked to diabetes and immune function |
| UCP3 | Uncoupling protein 3, regulates fatty acid metabolism | Implicated in obesity and muscle metabolism |
| LETM1 | Mitochondrial calcium/proton exchanger | Overexpression causes mitochondrial dysfunction and apoptosis |
| ANT1 (SLC25A4) | ADP/ATP translocase | Mutations cause mitochondrial DNA instability and myopathy |
| ANT2 (SLC25A5) | ADP/ATP translocase isoform | Highly expressed in proliferating cells and cancer |
| PiC (SLC25A3) | Phosphate carrier | Essential for ATP synthesis; mutations cause cardiomyopathy |
| NDUFA1 | Complex I subunit | Mutations linked to mitochondrial encephalomyopathy |
| SDHA | Complex II subunit | Tumor suppressor in paraganglioma and pheochromocytoma |
| UQCRB | Complex III subunit | Involved in ROS production and cancer metabolism |
| COX4I1 | Complex IV subunit | Regulates cytochrome c oxidase activity and ATP synthesis |
| ATP5F1A | ATP synthase alpha subunit | Target for cancer metabolism and mitochondrial disease |
| ATP5F1B | ATP synthase beta subunit | Mutations associated with mitochondrial disorders |
| PPARGC1A (PGC-1α) | Master regulator of mitochondrial biogenesis | Key for metabolic adaptation and exercise response |
| AMPK (PRKAA1/2) | Energy sensor kinase | Regulates mitochondrial function and ATP synthesis |
How Is regulation of mitochondrial ATP synthesis coupled proton transport Regulated?
The regulation of mitochondrial ATP synthesis coupled proton transport is itself subject to multiple layers of control. At the transcriptional level, PGC-1α (PPARGC1A) coordinates the expression of respiratory chain and ATP synthase subunits in response to energy demand. At the post-translational level, ATP synthase activity can be modulated by phosphorylation, acetylation, and interaction with inhibitory proteins such as IF1. Calcium signaling stimulates mitochondrial dehydrogenases and ATP synthesis to match workload. Uncoupling proteins are regulated by fatty acids, nucleotides, and ROS, providing a rapid mechanism to adjust proton leak. In immune cells, metabolic reprogramming during activation involves changes in mitochondrial ATP synthesis and proton transport. These regulatory mechanisms ensure that ATP production is dynamically matched to cellular needs and can be disrupted in disease.
regulation of mitochondrial ATP synthesis coupled proton transport and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| MT-ATP6 | Mitochondrial myopathy, neuropathy ataxia retinitis pigmentosa | Knock-in of patient mutations in cybrid cells |
| UCP1 | Obesity, thermogenesis defects | UCP1 knockout mouse, brown adipocyte overexpression |
| LETM1 | Cardiomyocyte stress, apoptosis | Overexpression in cultured cardiomyocytes |
| ANT1 (SLC25A4) | Mitochondrial DNA instability myopathy | Knockout in skeletal muscle cells |
| PPARGC1A | Metabolic syndrome, insulin resistance | Liver-specific knockout or overexpression |
Mitochondrial myopathies and cardiomyopathies
Mutations in genes encoding ATP synthase subunits or ADP/ATP translocases impair ATP synthesis coupled proton transport, leading to muscle weakness, cardiomyopathy, and exercise intolerance. In heart failure, reverse ATP synthase activity can deplete ATP and worsen contractile dysfunction. Elevated Letm1 levels in cardiomyocytes drive mitochondrial dysfunction and apoptosis, contributing to cardiac stress.
Neurodegeneration and ischemic stroke
Mitochondrial ATP synthesis and proton transport are critical for neuronal survival after ischemic stroke. The Pbx3/Dguok/Kif21b signaling pathway has been shown to synergistically mitigate oligodendrocyte progenitor cell dysfunction following transient middle cerebral artery occlusion by regulating mitochondrial ATP synthesis and proton transport. This suggests that targeting these regulators could promote recovery after stroke.
Metabolic disorders and immunometabolism
Uncoupling proteins and proton leak influence whole-body energy expenditure and insulin sensitivity. In immune cells, the electron transport chain and ATP synthesis are rewired during activation, and dysregulation contributes to inflammatory diseases. Modulating proton transport and ATP synthesis may offer therapeutic strategies for obesity, diabetes, and autoimmune conditions.
From regulation of mitochondrial ATP synthesis coupled proton transport-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of ATP synthase subunit impair ATP synthesis? | CRISPR knockout of MT-ATP6 in HeLa or HEK293 cells |
| Does a point mutation in UCP1 alter proton leak? | CRISPR point mutation knock-in in brown adipocytes |
| Does overexpression of Letm1 induce apoptosis? | Lentiviral overexpression in cardiomyocytes |
| Does a tagged ATP synthase allow live imaging? | CRISPR knock-in of fluorescent tag at ATP5F1A locus |
| Does knockout of ANT1 affect mitochondrial morphology? | CRISPR knockout in mouse embryonic fibroblasts |
| Does activation of AMPK increase ATP synthesis? | CRISPR knock-in of constitutively active AMPK |
How to Study the regulation of mitochondrial ATP synthesis coupled proton transport Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Seahorse XF | Oxygen consumption rate, proton leak, ATP-linked respiration | Assessing mitochondrial function in knockout cells |
| TMRM/JC-1 imaging | Mitochondrial membrane potential | Detecting changes in proton gradient |
| ATP luminescence | Total ATP levels | Quantifying energy status after gene editing |
| CRISPR screen | Enrichment of sgRNAs affecting ATP synthesis | Identifying novel regulators |
| Western blot | Protein levels of respiratory chain subunits | Validating knockout or overexpression |
| Blue native PAGE | Respiratory chain supercomplex assembly | Assessing complex integrity |
| Mitochondrial swelling assay | Proton permeability of inner membrane | Measuring uncoupling activity |
| RNA-seq | Transcriptional changes in metabolic genes | Profiling cellular response to genetic perturbation |
Seahorse extracellular flux analysis
The Seahorse XF analyzer measures oxygen consumption rate (OCR) and extracellular acidification rate (ECAR) to assess mitochondrial respiration and glycolysis in live cells. This method is widely used to evaluate the regulation of ATP synthesis coupled proton transport by calculating ATP-linked OCR and proton leak.
Mitochondrial membrane potential and pH measurements
Fluorescent dyes such as TMRM and JC-1 measure mitochondrial membrane potential, while pH-sensitive probes can assess matrix pH. These techniques reveal changes in the proton gradient that drives ATP synthesis.
ATP luminescence assays
Luciferase-based ATP assays quantify total cellular or mitochondrial ATP levels. When combined with inhibitors of oxidative phosphorylation, they can distinguish between glycolytic and mitochondrial ATP production.
Genetic screens and CRISPR libraries
Genome-wide CRISPR knockout or activation screens can identify regulators of mitochondrial ATP synthesis coupled proton transport. Cells are sorted based on mitochondrial membrane potential or ATP levels, and sgRNAs are sequenced to identify enriched genes.
How CRISPR Can Be Used to Study GO:1905706 regulation of mitochondrial ATP synthesis coupled proton transport
Knockout
CRISPR knockout of genes such as UCP1, LETM1, or ANT1 allows researchers to determine their essential roles in regulating mitochondrial ATP synthesis coupled proton transport. For example, knockout of UCP1 in brown adipocytes abolishes thermogenic proton leak, while knockout of ANT1 impairs ADP/ATP exchange and reduces ATP synthesis. These models are crucial for causal inference.
Point Mutation
CRISPR point mutation knock-in can recreate disease-associated mutations in genes like MT-ATP6 or UCP1 to study their effects on proton transport and ATP synthesis. This approach provides isogenic controls and reveals subtle regulatory changes that knockout cannot address.
Knock-in
Knock-in of fluorescent tags (e.g., GFP or mCherry) at endogenous loci such as ATP5F1A enables live-cell imaging of ATP synthase localization and dynamics. Tagged knock-in models also facilitate proteomic analysis of respiratory chain complexes.
Overexpression
CRISPR activation (CRISPRa) or lentiviral overexpression of genes like LETM1 or PGC-1α can drive increased mitochondrial ATP synthesis or proton leak, mimicking pathological states. Overexpression of Letm1 in cardiomyocytes induces mitochondrial dysfunction and apoptosis, providing a model for cardiac stress.
How EDITGENE Supports regulation of mitochondrial ATP synthesis coupled proton transport Research
Researchers studying regulation of mitochondrial ATP synthesis coupled proton transport-related genes often need to determine whether a candidate gene is causally involved in the pathway or merely correlated with changes in mitochondrial function. EDITGENE provides a comprehensive suite of CRISPR-based services to generate precisely engineered cell models that answer these questions.
Contact EDITGENE today to design your custom CRISPR model for regulation of mitochondrial ATP synthesis coupled proton transport research.
Frequently Asked Questions About regulation of mitochondrial ATP synthesis coupled proton transport
What is GO:1905706?
GO:1905706 is a Gene Ontology biological process term that describes the regulation of mitochondrial ATP synthesis coupled to proton transport. It encompasses any mechanism that modulates the production of ATP linked to proton movement across the inner mitochondrial membrane.
What genes are involved in regulation of mitochondrial ATP synthesis coupled proton transport?
Key genes include MT-ATP6, MT-ATP8, UCP1, UCP2, UCP3, LETM1, ANT1 (SLC25A4), ANT2 (SLC25A5), PiC (SLC25A3), and PPARGC1A (PGC-1α), among others.
How is mitochondrial ATP synthesis coupled to proton transport?
The respiratory chain pumps protons to create a gradient, and ATP synthase uses the return flow of protons to drive ATP synthesis. This coupling is regulated by proton leak, uncoupling proteins, and signaling pathways.
What diseases are associated with defects in this process?
Defects are linked to mitochondrial myopathies, cardiomyopathies, neurodegeneration, ischemic stroke, obesity, diabetes, and cancer metabolism.
What is the role of uncoupling proteins in this process?
Uncoupling proteins such as UCP1 mediate proton leak, dissipating the proton gradient as heat and thereby regulating the efficiency of ATP synthesis.
How can CRISPR be used to study this pathway?
CRISPR knockout, point mutation knock-in, tagged knock-in, and overexpression models allow researchers to test the causal role of specific genes in regulating ATP synthesis and proton transport.
What methods measure mitochondrial ATP synthesis coupled proton transport?
Seahorse extracellular flux analysis, TMRM/JC-1 imaging, ATP luminescence assays, and CRISPR screens are commonly used to assess this process.
What is the role of Letm1 in mitochondrial function?
Letm1 is a mitochondrial calcium/proton exchanger; its overexpression drives mitochondrial dysfunction and apoptosis in cardiomyocytes, linking it to cardiac stress.
Can reverse ATP synthase activity be targeted therapeutically?
Inhibition of reverse ATP synthase activity has been shown to restore energy homeostasis in mitochondrial pathologies, suggesting a therapeutic strategy.
How does immunometabolism relate to this GO term?
Immune cell activation involves metabolic reprogramming of the electron transport chain and ATP synthesis, and dysregulation contributes to inflammatory diseases.
Conclusion
GO:1905706, regulation of mitochondrial ATP synthesis coupled proton transport, is a fundamental biological process that integrates energy metabolism with cellular signaling. Its dysregulation underlies a wide range of human diseases, from cardiomyopathy to neurodegeneration. Advances in CRISPR-based gene editing and functional assays are enabling researchers to dissect the precise roles of individual regulators, paving the way for targeted therapies that modulate mitochondrial efficiency.
References
- 1. Vercellino I et al.. 2022. The assembly, regulation and function of the mitochondrial respiratory chain.. Nat Rev Mol Cell Biol 23(2):141-161 PMID: 34621061
- 2. Zhao RZ et al.. 2019. Mitochondrial electron transport chain, ROS generation and uncoupling (Review).. Int J Mol Med 44(1):3-15 PMID: 31115493
- 3. Acin-Perez R et al.. 2023. Inhibition of ATP synthase reverse activity restores energy homeostasis in mitochondrial pathologies.. EMBO J 42(10):e111699 PMID: 36912136
- 4. Jones SA et al.. 2024. Structural mechanisms of mitochondrial uncoupling protein 1 regulation in thermogenesis.. Trends Biochem Sci 49(6):506-519 PMID: 38565497
- 5. Deshpande A et al.. 2025. Elevated levels of Letm1 drives mitochondrial dysfunction and cardiomyocyte stress-mediated apoptosis in cultured cardiomyocytes.. Cell Commun Signal 23(1):378 PMID: 40849623
- 6. Divakaruni AS et al.. 2011. The regulation and physiology of mitochondrial proton leak.. Physiology (Bethesda) 26(3):192-205 PMID: 21670165
- 7. Li Y et al.. 2024. Mitochondrial ATP Synthesis and Proton Transport Synergistically Mitigate Oligodendrocyte Progenitor Cell Dysfunction Following Transient Middle Cerebral Artery Occlusion via the Pbx3/Dguok/Kif21b Signaling Pathway.. Int J Med Sci 21(11):2189-2200 PMID: 39239553
- 8. Zotta A et al.. 2024. Unlocking potential: the role of the electron transport chain in immunometabolism.. Trends Immunol 45(4):259-273 PMID: 38503657
